Evidence map›Paper›PMID 41871078›Full record

ArticlePLoS neglected tropical diseases2026

Development and pilot application of a point-of-need molecular xenomonitoring protocol for tsetse (Glossina sp.) in a low-resource setting.

Isabel Saldanha, Edward Aziku, Alex T Trima, Victor Drapari, Gala Garrod, Henry Ombanya, Inaki Tirados, Martha Betson, Albert Mugenyi, Sophie Dunkley and 3 more

Abstract readValidation Study
In one paragraph

Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Isabel SaldanhaDepartment of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.ORCID https://orcid.org/0000-0003-4141-8625
Edward AzikuDepartment of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Alex T TrimaDepartment of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Victor DrapariDepartment of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Gala GarrodDepartment of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Henry OmbanyaDepartment of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Inaki TiradosDepartment of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Martha BetsonSchool of Veterinary Medicine, University of Surrey, Guildford, United Kingdom.
Albert MugenyiCoordinating Office for Control of Trypanosomiasis in Uganda (COCTU), Ministry of Agriculture, Animal Industry and Fisheries, Kampala, Uganda.
Sophie DunkleyDepartment of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Stephen J TorrDepartment of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Andrew HopeDepartment of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Lucas J CunninghamDepartment of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTsetse flies (Glossina sp.) are the primary vectors of trypanosomes causing human African trypanosomiasis (HAT) and animal African trypanosomiasis (AAT). Disease surveillance can be carried out by detecting Trypanosoma DNA in tsetse, also known as molecular xenomonitoring. Whilst molecular methods can increase the efficiency and sensitivity of pathogen detection, trained staff and a well-equipped laboratory are required. In many cases, DNA extraction and screening is outsourced to a central laboratory in a major city either in-country or abroad, far removed from original tsetse collection sites. This increases results turnaround time, incurs transportation costs, and can lead to sample loss or damage. METHODOLOGY/PRINCIPLE

findingsWe set out to develop, optimise and trial methods for tsetse xenomonitoring in a low-resource point-of-need setting. A low-cost protocol was developed consisting of rapid alkali-based DNA extraction and Trypanosoma detection qPCR assays using air-dryable reagent mixes. A minimally-equipped laboratory was established in a field station in Arua, Uganda. Following a training workshop, three entomology technicians carried out screening on 286 tsetse collected over a nine-week study period. The technicians consistently extracted high quality DNA (98% success rate) and were able to successfully detect T. brucei sensu lato in 4.3% (95% confidence interval (CI) [2.23 - 7.37]), T. congolense in 3.6% (95% CI [1.73 - 6.47]) and T. vivax in 3.9% (95% CI [1.98 - 6.92]) of total tsetse, representing a total Trypanosoma sp detection prevalence of 10.7% (95% CI [9.6 - 11.8]). CONCLUSIONS/SIGNIFICANCE: This study demonstrated that sensitive molecular xenomonitoring of HAT and AAT pathogens can be carried out without the need for cold-chain storage or high-powered equipment. Further improvements to the system might be achieved by modifying the DNA extraction protocol to enable high-throughput or pooled samples, increasing the sensitivity of the T. b. gambiense DNA detection assay and exploring more sustainable power sources.

Indexed as

Molecular Diagnostic TechniquesTrypanosomaTrypanosomiasis, AfricanTsetse FliesAnimalsDNA, ProtozoanEpidemiological MonitoringHumansInsect VectorsPilot ProjectsReal-Time Polymerase Chain ReactionResource-Limited SettingsSensitivity and SpecificityUgandaDNA, Protozoan

Identifiers

PMID41871078
PMCPMC13035148

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.